Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals

Mohammed A. Medhat, Mohamed El‐Kassas, Haidi Karam-Allah, Ahmed Al Shafie, Sherief Abd‐Elsalam, Ehab Moustafa, Sahar M. Hassany, Marwa Salama, Mohamed S. Abd Elghafar, Hamdy Sayed, Mohamed Badr, Dalia Tarik Kamal, Ahmed Shamseldeen, Ashima'a Ossimi, Inas Moaz, Hossam El-deen Esmael, Azza M. Ezz Eldin, Sameera Ezzat, Hossam M. Abdelghaffar, Khaled Abdel-Ghaffar